Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

OXCARBAZEPINE CRS (130 MG)

OXCARBAZEPINE CRS (130 MG)

28721-07-5

DISCOVER
ISOPRENALINE IMPURITY A CRS (15 MG)

ISOPRENALINE IMPURITY A CRS (15 MG)

16899-81-3

DISCOVER
SILDENAFIL CITRATE CRS (100 MG)

SILDENAFIL CITRATE CRS (100 MG)

171599-83-0

DISCOVER
SILDENAFIL IMPURITY A CRS (5 MG)

SILDENAFIL IMPURITY A CRS (5 MG)

NA

DISCOVER
ROCURONIUM BROMIDE CRS (20 MG)

ROCURONIUM BROMIDE CRS (20 MG)

119302-91-9

DISCOVER
ALIMEMAZINE FOR SYSTEM SUITABILITY CRS (5 MG)

ALIMEMAZINE FOR SYSTEM SUITABILITY CRS (5 MG)

4330-99-8

DISCOVER
DESLORATADINE FOR SYSTEM SUITABILITY CRS (5 MG)

DESLORATADINE FOR SYSTEM SUITABILITY CRS (5 MG)

100643-71-8

DISCOVER
ALIMEMAZINE HEMITARTRATE CRS (15 MG)

ALIMEMAZINE HEMITARTRATE CRS (15 MG)

4330-99-8

DISCOVER
DESLORATADINE CRS (100 MG)

DESLORATADINE CRS (100 MG)

100643-71-8

DISCOVER
CELLULOSE ACETATE BUTYRATE CRS (60 MG)

CELLULOSE ACETATE BUTYRATE CRS (60 MG)

9004-36-8

DISCOVER
ATOMOXETINE HYDROCHLORIDE CRS(110 MG)

ATOMOXETINE HYDROCHLORIDE CRS(110 MG)

82248-59-7

DISCOVER
ATOMOXETINE FOR IMPURITY A IDENTIFICATION CRS (10 MG)

ATOMOXETINE FOR IMPURITY A IDENTIFICATION CRS (10 MG)

82248-59-7

DISCOVER